GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asiatic Laboratories Ltd (DHA:ASIATICLAB) » Definitions » EV-to-EBITDA

Asiatic Laboratories (DHA:ASIATICLAB) EV-to-EBITDA : (As of May. 23, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Asiatic Laboratories EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Asiatic Laboratories's enterprise value is BDT7,955.58 Mil. Asiatic Laboratories does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Asiatic Laboratories's EV-to-EBITDA at this moment.

The historical rank and industry rank for Asiatic Laboratories's EV-to-EBITDA or its related term are showing as below:

DHA:ASIATICLAB's EV-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 14.535
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-23), Asiatic Laboratories's stock price is BDT65.00. Asiatic Laboratories does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Asiatic Laboratories's PE Ratio at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Asiatic Laboratories EV-to-EBITDA Historical Data

The historical data trend for Asiatic Laboratories's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asiatic Laboratories EV-to-EBITDA Chart

Asiatic Laboratories Annual Data
Trend
EV-to-EBITDA

Asiatic Laboratories Semi-Annual Data
EV-to-EBITDA

Competitive Comparison of Asiatic Laboratories's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Asiatic Laboratories's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asiatic Laboratories's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Asiatic Laboratories's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Asiatic Laboratories's EV-to-EBITDA falls into.



Asiatic Laboratories EV-to-EBITDA Calculation

Asiatic Laboratories's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=7955.575/
=


Asiatic Laboratories  (DHA:ASIATICLAB) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Asiatic Laboratories's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=65.00/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Asiatic Laboratories EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Asiatic Laboratories's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Asiatic Laboratories (DHA:ASIATICLAB) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Siddeshwari Circular Road, 42-43, Treasure Island (5 th Floor) Shantinagar, Dhaka, BGD, 1217
Asiatic Laboratories Ltd is engaged in manufacturing and marketing of a wide range of the rapeutical medicines pharmaceutical products in the categories of Biological, Non-Biological & Sterile Pharmaceutical dosage. It has 80 generic molecules comprising therapeutic classes like antibiotics, antihistamines, bronchodilators, vitamins-minerals, antiulcerants, laxatives, gastroprokinetics, antihematinic, anthelmentics, CNS drugs, respiratory drugs, NSAIDs, dermatological preparations and sterile ophthalmic preparations.

Asiatic Laboratories (DHA:ASIATICLAB) Headlines

No Headlines